Although p53 remains wild-type in approximately 87 % of carcinomas, in ccRCC, its functional activity is diminished [41], suggesting that the tumor-suppressive role of p53 in ccRCC may be compromised by unknown regulatory mechanisms. This evidence concerns the gene TP53 and carcinoma.